Corporate FinanceCardiff Oncology Burns Through $12M Per Quarter With 5 Quarters Of Cash RemainingViaNews Editorial Team (Finance)•Mar 7, 2026
Corporate FinanceCardiff Oncology faces potential $500M+ valuation hit as pivotal cancer trial data loomsViaNews Editorial Team (Finance)•Mar 7, 2026